Radiologic progression in a patient with non-small-cell lung cancer

Radiologic progression in a patient with non-small-cell lung cancer

Bibliographic Details
Main Authors:	Alok K Shetty, Vanita Noronha, Vijay Patil, Nandini Menon, Amit Joshi, Abhishek Mahajan, Rajeev Kumar, Kumar Prabhash
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Cancer Research, Statistics, and Treatment
Online Access:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=3;spage=586;epage=589;aulast=Shetty

Similar Items

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience
by: Vanita Noronha, et al.
Published: (2020-07-01)

Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management
by: Akhil Rajendra, et al.
Published: (2019-01-01)

Coexistence of epidermal growth factor receptor mutation and anaplastic lymphoma kinase translocation in non-small cell lung cancer: Do we know the treatment sequence?
by: Vikas T Talreja, et al.
Published: (2019-01-01)

Resistance mechanisms to epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Suresh Kumar Bondili, et al.
Published: (2020-01-01)

Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
by: Vikas T. Talreja, et al.
Published: (2020-01-01)

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
by: Vikas T. Talreja, et al.
Published: (2020-01-01)

Sequential treatment with alectinib in crizotinib-resistant non-small-cell lung cancer
by: Swaratika Majumdar, et al.
Published: (2018-01-01)

Authors' reply to Jiwnani et al.
by: Nandini Menon, et al.
Published: (2020-01-01)

Molecular tumor board: Case 2 – Evolution of resistance in anaplastic lymphoma kinase driven non-small-cell lung carcinoma
by: Akhil Kapoor, et al.
Published: (2020-01-01)

Oral metronomic therapy in head and neck cancer – Authors' reply
by: Vijay Patil, et al.
Published: (2021-01-01)

The efficacy and safety of first-line therapy for the epidermal growth factor receptor mutant non-small cell lung cancer in older versus younger patients: A pooled analysis of two randomized controlled trials
by: Akhil Kapoor, et al.
Published: (2020-01-01)

Skin rash: Disease or drug?
by: Shikhar Kumar, et al.
Published: (2020-01-01)

Lung cancer in the Indian subcontinent
by: Vanita Noronha, et al.
Published: (2016-01-01)

Synchronous primary of periampullary and lung cancer: A case report and review of literature
by: Vikas Talreja, et al.
Published: (2018-01-01)

Molecular tumor board: Case 1-Interplay of EGFR, MET and PD-L1 in non-small cell lung carcinoma
by: Akhil Kapoor, et al.
Published: (2019-01-01)

Cystic brain lesions: Guess the mess
by: Anurag Gupta, et al.
Published: (2018-01-01)

The story of two eyes- What to look for in the patient's eyes?
by: Vikas T Talreja, et al.
Published: (2019-01-01)

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
by: Vikas T Talreja, et al.
Published: (2019-01-01)

Neurological deterioration in a patient with lung cancer and brain metastasis
by: Ravi Krishna Madala, et al.
Published: (2020-01-01)

Authors' reply to Kies and Katna et al.
by: Vijay M Patil, et al.
Published: (2020-01-01)

Cancer thrombosis: Narrative review
by: Pritesh Naresh Munot, et al.
Published: (2020-01-01)

Authors' reply to Daddi
by: Pritesh Naresh Munot, et al.
Published: (2020-01-01)

Author Reply to: Sahoo, Batra et al. and Mullapally et al.
by: Akhil Rajendra, et al.
Published: (2019-01-01)

Authors' reply to Chandrasekharan et al. and Abbas
by: Akhil Kapoor, et al.
Published: (2020-01-01)

Delirium and seizures in a patient with head-and-neck squamous cell carcinoma on docetaxel, cisplatin, and 5-fluorouracil
by: Satvik Khaddar, et al.
Published: (2019-01-01)

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Authors' reply to Dhanushkodi et al. and Chalissery
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Leptomeningeal metastasis from extracranial solid tumors
by: Dilip Harindran Vallathol, et al.
Published: (2020-01-01)

Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer
by: Vijay Patil, et al.
Published: (2019-01-01)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
by: Vanita Noronha, et al.
Published: (2016-01-01)

Author Reply to Kapoor et al.
by: Lakhan Kashyap, et al.
Published: (2019-01-01)

Dermatofibrosarcoma protuberans of head and neck: Clinical outcome of nine cases treated with imatinib
by: Lakhan Kashyap, et al.
Published: (2019-01-01)

Authors' response to Vora and Rajpurohit
by: Vanita Noronha, et al.
Published: (2020-01-01)

Authors' reply to Kulkarni et al. and Wiwanitkit
by: Amit Kumar Agrawal, et al.
Published: (2020-01-01)

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
by: Jyoti Bhagatram Sharma, et al.
Published: (2021-02-01)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
by: Vanita Noronha, et al.
Published: (2020-01-01)

Cytomegalovirus infection in solid malignancies
by: Amit Kumar Agrawal, et al.
Published: (2020-01-01)

Palliative oral triple metronomic chemotherapy in a patient with head-and-neck cancer during the COVID-19 pandemic in India: A case report
by: Sachin Babanrao Dhumal, et al.
Published: (2020-01-01)

Rare case of Skene gland adenocarcinoma with RET-rearrangement
by: Suresh Kumar Bondili, et al.
Published: (2021-01-01)

Authors' reply to Kumar et al. and Kannan et al.
by: Vijai Simha, et al.
Published: (2020-01-01)